Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 1 hr 35 mins

S&P Futures
5,970.50
+12.25(+0.21%)
Dow Futures
43,975.00
+74.00(+0.17%)
Nasdaq Futures
20,962.75
+68.75(+0.33%)
Russell 2000 Futures
2,418.20
+12.40(+0.52%)
Crude Oil
70.93
-0.76(-1.06%)
Gold
2,678.00
+1.70(+0.06%)

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

9.65

+0.02

(+0.21%)

At close: 04:00PM EST

9.50

-0.15

(-1.55%)

Pre-Market:

07:00AM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	1.11B
Enterprise Value	986.28M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	53.53
Price/Book (mrq)	15.31
Enterprise Value/Revenue	62.37
Enterprise Value/EBITDA	-9.71

Trading Information

Stock Price History

Beta (5Y Monthly)	2.02
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	9.98
52 Week Low ³	1.79
50-Day Moving Average ³	7.69
200-Day Moving Average ³	5.71

Share Statistics

Avg Vol (3 month) ³	2.59M
Avg Vol (10 day) ³	1.73M
Shares Outstanding ⁵	114.85M
Implied Shares Outstanding ⁶	N/A
Float ⁸	83.26M
% Held by Insiders ¹	5.31%
% Held by Institutions ¹	92.75%
Shares Short (Oct 15, 2024) ⁴	14.53M
Short Ratio (Oct 15, 2024) ⁴	2.85
Short % of Float (Oct 15, 2024) ⁴	14.14%
Short % of Shares Outstanding (Oct 15, 2024) ⁴	12.65%
Shares Short (prior month Sep 13, 2024) ⁴	10.82M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-14,194.44%

Management Effectiveness

Return on Assets (ttm)	-56.90%
Return on Equity (ttm)	-473.39%

Income Statement

Revenue (ttm)	-333k
Revenue Per Share (ttm)	-0.00
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-78.03M
Net Income Avi to Common (ttm)	-161.09M
Diluted EPS (ttm)	-1.43
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	122.2M
Total Cash Per Share (mrq)	1.06
Total Debt (mrq)	215k
Total Debt/Equity (mrq)	0.30
Current Ratio (mrq)	2.31
Book Value Per Share (mrq)	0.63

Cash Flow Statement

Operating Cash Flow (ttm)	-73.24M
Levered Free Cash Flow (ttm)	-29.14M